
Global Gases for Pharmaceutical and Biotechnology Market Analysis and Forecast 2024-2030
Description
Global Gases for Pharmaceutical and Biotechnology Market Analysis and Forecast 2024-2030
Summary
According to APO Research, The global Gases for Pharmaceutical and Biotechnology market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Gases for Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Gases for Pharmaceutical and Biotechnology include Air Liquide, Taiyo Nippon Sanso, Messer Group, Matheson, Air Products, Coregas, Linde and SOL Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
In terms of production side, this report researches the Gases for Pharmaceutical and Biotechnology production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Gases for Pharmaceutical and Biotechnology by region (region level and country level), by Company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
This report presents an overview of global market for Gases for Pharmaceutical and Biotechnology, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Gases for Pharmaceutical and Biotechnology, also provides the consumption of main regions and countries. Of the upcoming market potential for Gases for Pharmaceutical and Biotechnology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gases for Pharmaceutical and Biotechnology sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Gases for Pharmaceutical and Biotechnology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Gases for Pharmaceutical and Biotechnology sales, projected growth trends, production technology, application and end-user industry.
Gases for Pharmaceutical and Biotechnology segment by Company
Air Liquide
Taiyo Nippon Sanso
Messer Group
Matheson
Air Products
Coregas
Linde
SOL Group
Gases for Pharmaceutical and Biotechnology segment by Type
Nitrogen
Carbon Dioxide
Oxygen
Others
Gases for Pharmaceutical and Biotechnology segment by Application
Laboratory
Pharmaceutical and Biotechnology Companies
Others
Gases for Pharmaceutical and Biotechnology segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gases for Pharmaceutical and Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gases for Pharmaceutical and Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gases for Pharmaceutical and Biotechnology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Gases for Pharmaceutical and Biotechnology production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Gases for Pharmaceutical and Biotechnology in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Gases for Pharmaceutical and Biotechnology manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gases for Pharmaceutical and Biotechnology sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: Middle East, Africa, Latin America by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
Table of Contents
200 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Gases for Pharmaceutical and Biotechnology Market by Type
- 1.2.1 Global Gases for Pharmaceutical and Biotechnology Market Size by Type, 2019 VS 2023 VS 2030
- 1.2.2 Nitrogen
- 1.2.3 Carbon Dioxide
- 1.2.4 Oxygen
- 1.2.5 Others
- 1.3 Gases for Pharmaceutical and Biotechnology Market by Application
- 1.3.1 Global Gases for Pharmaceutical and Biotechnology Market Size by Application, 2019 VS 2023 VS 2030
- 1.3.2 Laboratory
- 1.3.3 Pharmaceutical and Biotechnology Companies
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Gases for Pharmaceutical and Biotechnology Market Dynamics
- 2.1 Gases for Pharmaceutical and Biotechnology Industry Trends
- 2.2 Gases for Pharmaceutical and Biotechnology Industry Drivers
- 2.3 Gases for Pharmaceutical and Biotechnology Industry Opportunities and Challenges
- 2.4 Gases for Pharmaceutical and Biotechnology Industry Restraints
- 3 Global Gases for Pharmaceutical and Biotechnology Production Overview
- 3.1 Global Gases for Pharmaceutical and Biotechnology Production Capacity (2019-2030)
- 3.2 Global Gases for Pharmaceutical and Biotechnology Production by Region: 2019 VS 2023 VS 2030
- 3.3 Global Gases for Pharmaceutical and Biotechnology Production by Region
- 3.3.1 Global Gases for Pharmaceutical and Biotechnology Production by Region (2019-2024)
- 3.3.2 Global Gases for Pharmaceutical and Biotechnology Production by Region (2025-2030)
- 3.3.3 Global Gases for Pharmaceutical and Biotechnology Production Market Share by Region (2019-2030)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
- 4 Global Market Growth Prospects
- 4.1 Global Gases for Pharmaceutical and Biotechnology Revenue Estimates and Forecasts (2019-2030)
- 4.2 Global Gases for Pharmaceutical and Biotechnology Revenue by Region
- 4.2.1 Global Gases for Pharmaceutical and Biotechnology Revenue by Region: 2019 VS 2023 VS 2030
- 4.2.2 Global Gases for Pharmaceutical and Biotechnology Revenue by Region (2019-2024)
- 4.2.3 Global Gases for Pharmaceutical and Biotechnology Revenue by Region (2025-2030)
- 4.2.4 Global Gases for Pharmaceutical and Biotechnology Revenue Market Share by Region (2019-2030)
- 4.3 Global Gases for Pharmaceutical and Biotechnology Sales Estimates and Forecasts 2019-2030
- 4.4 Global Gases for Pharmaceutical and Biotechnology Sales by Region
- 4.4.1 Global Gases for Pharmaceutical and Biotechnology Sales by Region: 2019 VS 2023 VS 2030
- 4.4.2 Global Gases for Pharmaceutical and Biotechnology Sales by Region (2019-2024)
- 4.4.3 Global Gases for Pharmaceutical and Biotechnology Sales by Region (2025-2030)
- 4.4.4 Global Gases for Pharmaceutical and Biotechnology Sales Market Share by Region (2019-2030)
- 4.5 US & Canada
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 Middle East, Africa and Latin America
- 5 Market Competitive Landscape by Manufacturers
- 5.1 Global Gases for Pharmaceutical and Biotechnology Revenue by Manufacturers
- 5.1.1 Global Gases for Pharmaceutical and Biotechnology Revenue by Manufacturers (2019-2024)
- 5.1.2 Global Gases for Pharmaceutical and Biotechnology Revenue Market Share by Manufacturers (2019-2024)
- 5.1.3 Global Gases for Pharmaceutical and Biotechnology Manufacturers Revenue Share Top 10 and Top 5 in 2023
- 5.2 Global Gases for Pharmaceutical and Biotechnology Sales by Manufacturers
- 5.2.1 Global Gases for Pharmaceutical and Biotechnology Sales by Manufacturers (2019-2024)
- 5.2.2 Global Gases for Pharmaceutical and Biotechnology Sales Market Share by Manufacturers (2019-2024)
- 5.2.3 Global Gases for Pharmaceutical and Biotechnology Manufacturers Sales Share Top 10 and Top 5 in 2023
- 5.3 Global Gases for Pharmaceutical and Biotechnology Sales Price by Manufacturers (2019-2024)
- 5.4 Global Gases for Pharmaceutical and Biotechnology Key Manufacturers Ranking, 2022 VS 2023 VS 2024
- 5.5 Global Gases for Pharmaceutical and Biotechnology Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global Gases for Pharmaceutical and Biotechnology Manufacturers, Product Type & Application
- 5.7 Global Gases for Pharmaceutical and Biotechnology Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global Gases for Pharmaceutical and Biotechnology Market CR5 and HHI
- 5.8.2 2023 Gases for Pharmaceutical and Biotechnology Tier 1, Tier 2, and Tier 3
- 6 Gases for Pharmaceutical and Biotechnology Market by Type
- 6.1 Global Gases for Pharmaceutical and Biotechnology Revenue by Type
- 6.1.1 Global Gases for Pharmaceutical and Biotechnology Revenue by Type (2019 VS 2023 VS 2030)
- 6.1.2 Global Gases for Pharmaceutical and Biotechnology Revenue by Type (2019-2030) & (US$ Million)
- 6.1.3 Global Gases for Pharmaceutical and Biotechnology Revenue Market Share by Type (2019-2030)
- 6.2 Global Gases for Pharmaceutical and Biotechnology Sales by Type
- 6.2.1 Global Gases for Pharmaceutical and Biotechnology Sales by Type (2019 VS 2023 VS 2030)
- 6.2.2 Global Gases for Pharmaceutical and Biotechnology Sales by Type (2019-2030) & (Tons)
- 6.2.3 Global Gases for Pharmaceutical and Biotechnology Sales Market Share by Type (2019-2030)
- 6.3 Global Gases for Pharmaceutical and Biotechnology Price by Type
- 7 Gases for Pharmaceutical and Biotechnology Market by Application
- 7.1 Global Gases for Pharmaceutical and Biotechnology Revenue by Application
- 7.1.1 Global Gases for Pharmaceutical and Biotechnology Revenue by Application (2019 VS 2023 VS 2030)
- 7.1.2 Global Gases for Pharmaceutical and Biotechnology Revenue by Application (2019-2030) & (US$ Million)
- 7.1.3 Global Gases for Pharmaceutical and Biotechnology Revenue Market Share by Application (2019-2030)
- 7.2 Global Gases for Pharmaceutical and Biotechnology Sales by Application
- 7.2.1 Global Gases for Pharmaceutical and Biotechnology Sales by Application (2019 VS 2023 VS 2030)
- 7.2.2 Global Gases for Pharmaceutical and Biotechnology Sales by Application (2019-2030) & (Tons)
- 7.2.3 Global Gases for Pharmaceutical and Biotechnology Sales Market Share by Application (2019-2030)
- 7.3 Global Gases for Pharmaceutical and Biotechnology Price by Application
- 8 Company Profiles
- 8.1 Air Liquide
- 8.1.1 Air Liquide Comapny Information
- 8.1.2 Air Liquide Business Overview
- 8.1.3 Air Liquide Gases for Pharmaceutical and Biotechnology Sales, Revenue, Price and Gross Margin (2019-2024)
- 8.1.4 Air Liquide Gases for Pharmaceutical and Biotechnology Product Portfolio
- 8.1.5 Air Liquide Recent Developments
- 8.2 Taiyo Nippon Sanso
- 8.2.1 Taiyo Nippon Sanso Comapny Information
- 8.2.2 Taiyo Nippon Sanso Business Overview
- 8.2.3 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Sales, Revenue, Price and Gross Margin (2019-2024)
- 8.2.4 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Product Portfolio
- 8.2.5 Taiyo Nippon Sanso Recent Developments
- 8.3 Messer Group
- 8.3.1 Messer Group Comapny Information
- 8.3.2 Messer Group Business Overview
- 8.3.3 Messer Group Gases for Pharmaceutical and Biotechnology Sales, Revenue, Price and Gross Margin (2019-2024)
- 8.3.4 Messer Group Gases for Pharmaceutical and Biotechnology Product Portfolio
- 8.3.5 Messer Group Recent Developments
- 8.4 Matheson
- 8.4.1 Matheson Comapny Information
- 8.4.2 Matheson Business Overview
- 8.4.3 Matheson Gases for Pharmaceutical and Biotechnology Sales, Revenue, Price and Gross Margin (2019-2024)
- 8.4.4 Matheson Gases for Pharmaceutical and Biotechnology Product Portfolio
- 8.4.5 Matheson Recent Developments
- 8.5 Air Products
- 8.5.1 Air Products Comapny Information
- 8.5.2 Air Products Business Overview
- 8.5.3 Air Products Gases for Pharmaceutical and Biotechnology Sales, Revenue, Price and Gross Margin (2019-2024)
- 8.5.4 Air Products Gases for Pharmaceutical and Biotechnology Product Portfolio
- 8.5.5 Air Products Recent Developments
- 8.6 Coregas
- 8.6.1 Coregas Comapny Information
- 8.6.2 Coregas Business Overview
- 8.6.3 Coregas Gases for Pharmaceutical and Biotechnology Sales, Revenue, Price and Gross Margin (2019-2024)
- 8.6.4 Coregas Gases for Pharmaceutical and Biotechnology Product Portfolio
- 8.6.5 Coregas Recent Developments
- 8.7 Linde
- 8.7.1 Linde Comapny Information
- 8.7.2 Linde Business Overview
- 8.7.3 Linde Gases for Pharmaceutical and Biotechnology Sales, Revenue, Price and Gross Margin (2019-2024)
- 8.7.4 Linde Gases for Pharmaceutical and Biotechnology Product Portfolio
- 8.7.5 Linde Recent Developments
- 8.8 SOL Group
- 8.8.1 SOL Group Comapny Information
- 8.8.2 SOL Group Business Overview
- 8.8.3 SOL Group Gases for Pharmaceutical and Biotechnology Sales, Revenue, Price and Gross Margin (2019-2024)
- 8.8.4 SOL Group Gases for Pharmaceutical and Biotechnology Product Portfolio
- 8.8.5 SOL Group Recent Developments
- 9 North America
- 9.1 North America Gases for Pharmaceutical and Biotechnology Market Size by Type
- 9.1.1 North America Gases for Pharmaceutical and Biotechnology Revenue by Type (2019-2030)
- 9.1.2 North America Gases for Pharmaceutical and Biotechnology Sales by Type (2019-2030)
- 9.1.3 North America Gases for Pharmaceutical and Biotechnology Price by Type (2019-2030)
- 9.2 North America Gases for Pharmaceutical and Biotechnology Market Size by Application
- 9.2.1 North America Gases for Pharmaceutical and Biotechnology Revenue by Application (2019-2030)
- 9.2.2 North America Gases for Pharmaceutical and Biotechnology Sales by Application (2019-2030)
- 9.2.3 North America Gases for Pharmaceutical and Biotechnology Price by Application (2019-2030)
- 9.3 North America Gases for Pharmaceutical and Biotechnology Market Size by Country
- 9.3.1 North America Gases for Pharmaceutical and Biotechnology Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
- 9.3.2 North America Gases for Pharmaceutical and Biotechnology Sales by Country (2019 VS 2023 VS 2030)
- 9.3.3 North America Gases for Pharmaceutical and Biotechnology Price by Country (2019-2030)
- 9.3.4 United States
- 9.3.5 Canada
- 10 Europe
- 10.1 Europe Gases for Pharmaceutical and Biotechnology Market Size by Type
- 10.1.1 Europe Gases for Pharmaceutical and Biotechnology Revenue by Type (2019-2030)
- 10.1.2 Europe Gases for Pharmaceutical and Biotechnology Sales by Type (2019-2030)
- 10.1.3 Europe Gases for Pharmaceutical and Biotechnology Price by Type (2019-2030)
- 10.2 Europe Gases for Pharmaceutical and Biotechnology Market Size by Application
- 10.2.1 Europe Gases for Pharmaceutical and Biotechnology Revenue by Application (2019-2030)
- 10.2.2 Europe Gases for Pharmaceutical and Biotechnology Sales by Application (2019-2030)
- 10.2.3 Europe Gases for Pharmaceutical and Biotechnology Price by Application (2019-2030)
- 10.3 Europe Gases for Pharmaceutical and Biotechnology Market Size by Country
- 10.3.1 Europe Gases for Pharmaceutical and Biotechnology Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
- 10.3.2 Europe Gases for Pharmaceutical and Biotechnology Sales by Country (2019 VS 2023 VS 2030)
- 10.3.3 Europe Gases for Pharmaceutical and Biotechnology Price by Country (2019-2030)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Netherlands
- 11 China
- 11.1 China Gases for Pharmaceutical and Biotechnology Market Size by Type
- 11.1.1 China Gases for Pharmaceutical and Biotechnology Revenue by Type (2019-2030)
- 11.1.2 China Gases for Pharmaceutical and Biotechnology Sales by Type (2019-2030)
- 11.1.3 China Gases for Pharmaceutical and Biotechnology Price by Type (2019-2030)
- 11.2 China Gases for Pharmaceutical and Biotechnology Market Size by Application
- 11.2.1 China Gases for Pharmaceutical and Biotechnology Revenue by Application (2019-2030)
- 11.2.2 China Gases for Pharmaceutical and Biotechnology Sales by Application (2019-2030)
- 11.2.3 China Gases for Pharmaceutical and Biotechnology Price by Application (2019-2030)
- 12 Asia (Excluding China)
- 12.1 Asia Gases for Pharmaceutical and Biotechnology Market Size by Type
- 12.1.1 Asia Gases for Pharmaceutical and Biotechnology Revenue by Type (2019-2030)
- 12.1.2 Asia Gases for Pharmaceutical and Biotechnology Sales by Type (2019-2030)
- 12.1.3 Asia Gases for Pharmaceutical and Biotechnology Price by Type (2019-2030)
- 12.2 Asia Gases for Pharmaceutical and Biotechnology Market Size by Application
- 12.2.1 Asia Gases for Pharmaceutical and Biotechnology Revenue by Application (2019-2030)
- 12.2.2 Asia Gases for Pharmaceutical and Biotechnology Sales by Application (2019-2030)
- 12.2.3 Asia Gases for Pharmaceutical and Biotechnology Price by Application (2019-2030)
- 12.3 Asia Gases for Pharmaceutical and Biotechnology Market Size by Country
- 12.3.1 Asia Gases for Pharmaceutical and Biotechnology Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
- 12.3.2 Asia Gases for Pharmaceutical and Biotechnology Sales by Country (2019 VS 2023 VS 2030)
- 12.3.3 Asia Gases for Pharmaceutical and Biotechnology Price by Country (2019-2030)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 China Taiwan
- 12.3.9 Southeast Asia
- 13 Middle East, Africa and Latin America
- 13.1 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Market Size by Type
- 13.1.1 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Revenue by Type (2019-2030)
- 13.1.2 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Sales by Type (2019-2030)
- 13.1.3 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Price by Type (2019-2030)
- 13.2 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Market Size by Application
- 13.2.1 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Revenue by Application (2019-2030)
- 13.2.2 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Sales by Application (2019-2030)
- 13.2.3 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Price by Application (2019-2030)
- 13.3 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Market Size by Country
- 13.3.1 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
- 13.3.2 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Sales by Country (2019 VS 2023 VS 2030)
- 13.3.3 Middle East, Africa and Latin America Gases for Pharmaceutical and Biotechnology Price by Country (2019-2030)
- 13.3.4 Mexico
- 13.3.5 Brazil
- 13.3.6 Israel
- 13.3.7 Argentina
- 13.3.8 Colombia
- 13.3.9 Turkey
- 13.3.10 Saudi Arabia
- 13.3.11 UAE
- 14 Value Chain and Sales Channels Analysis
- 14.1 Gases for Pharmaceutical and Biotechnology Value Chain Analysis
- 14.1.1 Gases for Pharmaceutical and Biotechnology Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 Gases for Pharmaceutical and Biotechnology Production Mode & Process
- 14.2 Gases for Pharmaceutical and Biotechnology Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 Gases for Pharmaceutical and Biotechnology Distributors
- 14.2.3 Gases for Pharmaceutical and Biotechnology Customers
- 15 Concluding Insights
- 16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.